Genetic background determines the extent of atherosclerosis in ApoE-deficient mice

scientific article published on 01 August 1999

Genetic background determines the extent of atherosclerosis in ApoE-deficient mice is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1161/01.ATV.19.8.1960
P698PubMed publication ID10446078

P50authorRonit SimantovQ71747729
P2093author name stringJ L Breslow
J D Smith
K J Moore
H M Dansky
S A Charlton
S C Heath
P Shu
J L Sikes
L F Levin
P433issue8
P304page(s)1960-1968
P577publication date1999-08-01
P1433published inArteriosclerosis, Thrombosis, and Vascular BiologyQ4797542
P1476titleGenetic background determines the extent of atherosclerosis in ApoE-deficient mice
P478volume19

Reverse relations

cites work (P2860)
Q36085701A change in inflammatory footprint precedes plaque instability: a systematic evaluation of cellular aspects of the adaptive immune response in human atherosclerosis
Q34614796A phenotype-sensitizing Apoe-deficient genetic background reveals novel atherosclerosis predisposition loci in the mouse
Q33716142A20, a regulator of NFκB, maps to an atherosclerosis locus and differs between parental sensitive C57BL/6J and resistant FVB/N strains
Q35286806Adipocyte enhancer-binding protein 1 (AEBP1) (a novel macrophage proinflammatory mediator) overexpression promotes and ablation attenuates atherosclerosis in ApoE (-/-) and LDLR (-/-) mice
Q34478995Adipocyte enhancer-binding protein 1 is a potential novel atherogenic factor involved in macrophage cholesterol homeostasis and inflammation
Q34368686Advances in experimental dyslipidemia and atherosclerosis
Q37609178Altered expression of Raet1e, a major histocompatibility complex class 1-like molecule, underlies the atherosclerosis modifier locus Ath11 10b.
Q36296729Anatomical differences and atherosclerosis in apolipoprotein E-deficient mice with 129/SvEv and C57BL/6 genetic backgrounds
Q35147157Animal models of calcific aortic valve disease
Q36843340ApoE knockout and knockin mice: the history of their contribution to the understanding of atherogenesis
Q33846064Apolipoprotein E deficiency abrogates insulin resistance in a mouse model of type 2 diabetes mellitus
Q31925840Apolipoprotein E deficiency effects on learning in mice are dependent upon the background strain
Q30440513Association of a Vcam1 mutation with atherosclerosis susceptibility in diet-induced models of atherosclerosis
Q34248316Atherosclerosis quantitative trait loci are sex- and lineage-dependent in an intercross of C57BL/6 and FVB/N low-density lipoprotein receptor-/- mice
Q29618972Atherosclerosis. the road ahead
Q46918588Cell adhesion molecules and eNOS expression in aorta of normocholesterolemic mice with different predispositions to atherosclerosis
Q38479492Changes in transcriptome of macrophages in atherosclerosis
Q34046144Chronic senolytic treatment alleviates established vasomotor dysfunction in aged or atherosclerotic mice.
Q50187702Consideration of Sex Differences in Design and Reporting of Experimental Arterial Pathology Studies-Statement From ATVB Council.
Q34022703Designing phenotyping studies for genetically engineered mice
Q38333634Diet × genotype interactions in hepatic cholesterol and lipoprotein metabolism in Atlantic salmon (Salmo salar) in response to replacement of dietary fish oil with vegetable oil.
Q37076522Differing rates of cholesterol absorption among inbred mouse strains yield differing levels of HDL-cholesterol
Q38888696Do the Apoe-/- and Ldlr-/- Mice Yield the Same Insight on Atherogenesis?
Q38651954Elevated tumor LDLR expression accelerates LDL cholesterol-mediated breast cancer growth in mouse models of hyperlipidemia
Q46049422Endothelial Nox4-based NADPH oxidase regulates atherosclerosis via soluble epoxide hydrolase
Q34082965Epigenetic coordination of embryonic heart transcription by dynamically regulated long noncoding RNAs
Q24313446Evidence for differential effects of apoE3 and apoE4 on HDL metabolism
Q43704009Freunds adjuvant alone is antiatherogenic in apoE-deficient mice and specific immunization against TNFalpha confers no additional benefit
Q39310748From Peas to Disease: Modifier Genes, Network Resilience, and the Genetics of Health
Q35393112Genetic analysis of ligation-induced neointima formation in an F2 intercross of C57BL/6 and FVB/N inbred mouse strains
Q34303420Genetic markers for coronary heart disease.
Q34080318Genetic modifiers of atherosclerosis in mice
Q42430561Genetics of common forms of heart disease: a long and winding road
Q34753930Gsk3β is required in the epithelium for palatal elevation in mice
Q37496309Haplotype analysis in multiple crosses to identify a QTL gene
Q46899113High-throughput phenotypic assessment of cardiac physiology in four commonly used inbred mouse strains
Q51744807Hypercholesterolemia-Induced Loss of Flow-Induced Vasodilation and Lesion Formation in Apolipoprotein E-Deficient Mice Critically Depend on Inwardly Rectifying K+ Channels.
Q37307577Impact of high fat diet on long non-coding RNAs and messenger RNAs expression in the aortas of ApoE(-/-) mice
Q64118875Increased Reactive Oxygen Species Generation Contributes to the Atherogenic Activity of the B2 Bradykinin Receptor
Q40882983Infection with Toxoplasma gondii increases atherosclerotic lesion in ApoE-deficient mice.
Q42150125Is the FVB/N mouse strain truly resistant to diet-induced obesity?
Q34470216Is there a genetic basis for resistance to atherosclerosis?
Q36940644Jnk1 Deficiency in Hematopoietic Cells Suppresses Macrophage Apoptosis and Increases Atherosclerosis in Low-Density Lipoprotein Receptor Null Mice.
Q36531841Localization of atherosclerosis susceptibility loci to chromosomes 4 and 6 using the Ldlr knockout mouse model
Q33905765Loss of receptor-mediated lipid uptake via scavenger receptor A or CD36 pathways does not ameliorate atherosclerosis in hyperlipidemic mice
Q33777669Mammary tumor growth and pulmonary metastasis are enhanced in a hyperlipidemic mouse model
Q46255275Manipulating the mouse genome: approaches and applications
Q37383999Mice generated by in vitro fertilization exhibit vascular dysfunction and shortened life span
Q41496727MicroRNA miR-301a is a novel cardiac regulator of Cofilin-2.
Q39194237Mitogen-activated protein kinase phosphatase 1 (MKP-1) in macrophage biology and cardiovascular disease. A redox-regulated master controller of monocyte function and macrophage phenotype
Q37398302Moderately decreased cholesterol absorption rates are associated with a large atheroprotective effect
Q35897053Naturally occurring variant of mouse apolipoprotein A-I alters the lipid and HDL association properties of the protein
Q34675880No reduction of atherosclerosis in C-reactive protein (CRP)-deficient mice
Q37335281Novel strategy using F1-congenic mice for validation of QTLs: studies at the proximal chromosome 10 atherosclerosis susceptibility locus
Q35775557Periodontal pathogens invade gingiva and aortic adventitia and elicit inflammasome activation in αvβ6 integrin-deficient mice
Q34042381Perspectives for vascular genomics
Q35092902Polymorphisms of mouse apolipoprotein A-II alter its physical and functional nature
Q37225813Pro-atherogenic role of smooth muscle Nox4-based NADPH oxidase
Q30443593Quantitative trait locus analysis of carotid atherosclerosis in an intercross between C57BL/6 and C3H apolipoprotein E-deficient mice
Q38366515Roles of p38α mitogen-activated protein kinase in mouse models of inflammatory diseases and cancer.
Q36753949Tenascin-C deficiency in apo E-/- mouse increases eotaxin levels: implications for atherosclerosis
Q44570731Testing the role of apoA-I, HDL, and cholesterol efflux in the atheroprotective action of low-level apoE expression
Q36893444The hemostasis system in murine atherosclerosis
Q41190747The induction of atherogenic dyslipidaemia in poloxamer 407-treated mice is not mediated through PPARalpha
Q34048456The mouse atherosclerosis locus at chromosome 10 (Ath11) acts early in lesion formation with subcongenic strains delineating 2 narrowed regions
Q34092815Transgenic overexpression of pregnancy-associated plasma protein-A in murine arterial smooth muscle accelerates atherosclerotic lesion development
Q43546745Variable association between genetic variation in the CYP7 gene promoter and plasma lipoproteins in three Canadian populations

Search more.